Real-world Study to Assess Adherence to IOP Lowering Therapy in Glaucoma Patients Using CONNECTDROP®: the GRANITE Study (Glaucoma tReatment AdhereNce wIth connecTed dEvice in Italy)

Status: Recruiting
Location: See all (15) locations...
Study Type: Observational
SUMMARY

The goal of this real-life, national, multicentre, prospective clinical investigation is to describe the adherence rate over time in patients with glaucoma already treated with IOP-lowering eye drops using connected device CONNECTDROP® The main questions it aims to answer are: * The mean annual adherence rate, defined as the percentage of the prescribed doses taken by the patient * The adherence profile of each patient * The association between the adherence profile, the objective adherence data and the clinical data. Participants will use the connected device CONNECTDROP® associated with the smartphone application on a daily basis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patient (≥ 18 years old), man or woman

• Patient with a diagnosis of bilateral open angle glaucoma

• Patients being prescribed with glaucoma eye drops in EASYGRIP® bottle for at least 6 weeks in monotherapy.

• Patient willing to participate in the study

• Patient who consents for data collection in the frame of the study

Locations
Other Locations
Italy
Besomed SRLS
NOT_YET_RECRUITING
Bari
Studio Oculistico D'Azeglio
NOT_YET_RECRUITING
Bologna
Centro Medico Polispecialistico Di Maita
NOT_YET_RECRUITING
Catania
Studio Medico Oculistico Dr.ssa Rosa SCHIAVELLI s.r.l.
NOT_YET_RECRUITING
Corigliano
Ospedale Policlinico S. Martino-IRCCS Clinica Oculistica Università di Genova
NOT_YET_RECRUITING
Genova
Poliambulatorio Chirurgico Modenese Eyecare Clinic
NOT_YET_RECRUITING
Modena
AOU Federico II di Napoli Dipartimento di Neuroscienze e Scienze Riproduttive ed Odontostomatologiche Università degli studi di Napoli Federico II U.O.C. di Oftalmologia
NOT_YET_RECRUITING
Napoli
Azienda Ospedale-Università Padova Ospedale Sant'Antonio UOC Oculistica
ACTIVE_NOT_RECRUITING
Padua
A.O.U. Pisana UO Oculistica Universitaria
NOT_YET_RECRUITING
Pisa
Fondazione PTV Policlinico Tor Vergata Fondazione PTV Policlinico Tor Vergata UOSD di Oculistica
NOT_YET_RECRUITING
Roma
IRCCS Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia ONLUS Presidio Ospedaliero Britannico Unità di Ricerca Glaucoma
ACTIVE_NOT_RECRUITING
Roma
AULSS 4 Veneto Orientale Ospedale di San Donà di Piave Dip. Oculistica
NOT_YET_RECRUITING
San Donà Di Piave
AOU Sassari Clinica Oculistica
NOT_YET_RECRUITING
Sassari
Studi Oculistici
RECRUITING
Seravezza
Humanitas Gradenigo U.O. Oculistica
NOT_YET_RECRUITING
Torino
Contact Information
Primary
Alice BODEVEIX
alice.bodeveix@theapharma.com
+33633942160
Time Frame
Start Date: 2025-09-19
Estimated Completion Date: 2027-03
Participants
Target number of participants: 200
Treatments
Group receiving T9060 CONNECTDROP
Related Therapeutic Areas
Sponsors
Leads: Laboratoires Thea

This content was sourced from clinicaltrials.gov